JP2955318B2 - 置換ピリミジン誘導体 - Google Patents

置換ピリミジン誘導体

Info

Publication number
JP2955318B2
JP2955318B2 JP2038507A JP3850790A JP2955318B2 JP 2955318 B2 JP2955318 B2 JP 2955318B2 JP 2038507 A JP2038507 A JP 2038507A JP 3850790 A JP3850790 A JP 3850790A JP 2955318 B2 JP2955318 B2 JP 2955318B2
Authority
JP
Japan
Prior art keywords
group
substituted
alkyl
methyl
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2038507A
Other languages
English (en)
Japanese (ja)
Other versions
JPH02255662A (ja
Inventor
カール・ガイゼン
ハンス・ヨヘン・ラング
ヒルデガルト・ニメスゲルン
クラウス・ヴアイトマン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of JPH02255662A publication Critical patent/JPH02255662A/ja
Application granted granted Critical
Publication of JP2955318B2 publication Critical patent/JP2955318B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2038507A 1989-02-22 1990-02-21 置換ピリミジン誘導体 Expired - Lifetime JP2955318B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3905364A DE3905364A1 (de) 1989-02-22 1989-02-22 Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
DE3905364.4 1989-02-22

Publications (2)

Publication Number Publication Date
JPH02255662A JPH02255662A (ja) 1990-10-16
JP2955318B2 true JP2955318B2 (ja) 1999-10-04

Family

ID=6374628

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2038507A Expired - Lifetime JP2955318B2 (ja) 1989-02-22 1990-02-21 置換ピリミジン誘導体

Country Status (18)

Country Link
US (1) US5138058A (pt)
EP (1) EP0384370B1 (pt)
JP (1) JP2955318B2 (pt)
KR (1) KR0142189B1 (pt)
AT (1) ATE96787T1 (pt)
AU (1) AU634751B2 (pt)
CA (1) CA2010588C (pt)
DE (2) DE3905364A1 (pt)
DK (1) DK0384370T3 (pt)
ES (1) ES2060829T3 (pt)
FI (1) FI95694C (pt)
IE (1) IE63570B1 (pt)
IL (1) IL93465A (pt)
NO (1) NO178431C (pt)
NZ (1) NZ232601A (pt)
PH (1) PH27222A (pt)
PT (1) PT93224B (pt)
ZA (1) ZA901309B (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662607B1 (fr) * 1990-05-30 1992-08-28 Oreal Composition destinee a etre utilisee pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives d'alkyl-2 amino-4 (ou dialkyl-2-4) pyrimidine oxyde-3 .
DE4025387A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als reagenzien
DE4142191A1 (de) * 1991-12-20 1993-06-24 Bayer Ag Verfahren zur herstellung von 3-alkoxy-acrylestern
ES2130258T3 (es) * 1992-04-28 1999-07-01 Yamanouchi Pharma Co Ltd Compuesto amino terciario sustituido o sal de este compuesto.
CA2145640C (en) * 1992-09-28 2001-01-30 Banavara L. Mylari Substituted pyrimidines for control of diabetic complications
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
AU1608397A (en) * 1996-02-02 1997-08-22 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
DE69711965T2 (de) * 1996-02-29 2003-01-23 Pfizer Inc., New York Verwendung von Sorbitol-Dehydrogenase-Inhibitoren zum Reduzieren von Ischämie-assozierten Gewebeschäden
JPH09301868A (ja) * 1996-05-10 1997-11-25 Senju Pharmaceut Co Ltd 抗白内障剤
TR199900303T2 (xx) * 1996-08-14 1999-06-21 Zeneca Limited �kame edilmi� pirimidin t�revleri ve bunlar�n farmas�tik kullan�m�.
WO1998014430A1 (fr) * 1996-10-02 1998-04-09 Sumitomo Pharmaceuticals Co., Ltd. Derives de pyrimidine
UA56197C2 (uk) 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
ATE242774T1 (de) 1997-02-13 2003-06-15 Astrazeneca Ab Heterozyklische verbindungen die als oxido- squalen-zyklase-inhibitoren anwendung finden
JP2001511798A (ja) 1997-02-13 2001-08-14 ゼネカ・リミテッド オキシド−スクアレンシクラーゼ抑制剤として有用な複素環化合物
DE19710435A1 (de) * 1997-03-13 1998-09-17 Hoechst Ag Verwendung von Pyrimidinderivaten zur Prävention von Krebs allein oder in Kombination mit anderen therapeutischen Maßnahmen
GB9715895D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
GB9902989D0 (en) 1999-02-11 1999-03-31 Zeneca Ltd Heterocyclic derivatives
ATE264311T1 (de) 1999-04-01 2004-04-15 Pfizer Prod Inc Verbindungen zur behandlung und vorsorge bei diabetes
MXPA01009871A (es) 1999-04-01 2002-04-24 Pfizer Prod Inc Aminopiridinas como inhibidores de la sorbitol deshidrogenasa.
EP1313713B1 (en) * 2000-08-08 2008-06-11 Ortho-McNeil Pharmaceutical, Inc. 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
PT1334094E (pt) 2000-11-02 2005-05-31 Hoffmann La Roche Benzo[b]tiofenos e benzo(d)isotiazoles para diminuir o colesterol
US6503907B2 (en) 2000-11-28 2003-01-07 Hoffmann-La Roche Inc. Indole and dihydroindole derivatives
EP1247809A3 (en) * 2001-03-30 2003-12-17 Pfizer Products Inc. Triazine compounds useful as sorbitol dehydrogenase inhibitors
US6825198B2 (en) * 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
WO2004000318A2 (en) * 2002-06-21 2003-12-31 Cellular Genomics, Inc. Certain amino-substituted monocycles as kinase modulators
US20040082627A1 (en) * 2002-06-21 2004-04-29 Darrow James W. Certain aromatic monocycles as kinase modulators
GB0323137D0 (en) * 2003-10-03 2003-11-05 Chang Lisa C W 2,4,6- Trisubstituted pyrimidines and their different uses
US7434592B2 (en) * 2003-10-10 2008-10-14 Millennial Medical Equipment, L.L.C. Ergonomic collapsible crutch
US7104271B2 (en) * 2003-10-10 2006-09-12 Millennial Medical Equipment, L.L.C. Ergonomic collapsible crutch
WO2005058883A1 (en) * 2003-12-15 2005-06-30 Almirall Prodesfarma Ag 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists
TWI355894B (en) * 2003-12-19 2012-01-11 Du Pont Herbicidal pyrimidines
DE602006020864D1 (de) * 2005-04-11 2011-05-05 Almirall Sa 2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten
AU2006326540A1 (en) * 2005-12-14 2007-06-21 Amgen Inc. Diaza heterocyclic sulfonamide derivatives and their uses
WO2008070661A1 (en) * 2006-12-04 2008-06-12 Neurocrine Biosciences, Inc. Substituted pyrimidines as adenosine receptor antagonists
ES2559528T3 (es) 2006-12-08 2016-02-12 Novartis Ag Compuestos y composiciones como inhibidores de proteína cinasa
EP2132197A2 (en) * 2007-03-21 2009-12-16 Almirall, S.A. Substituted pyrimidines as adenosine receptor antagonists
PT2142529E (pt) * 2007-04-27 2014-03-20 Purdue Pharma Lp Antagonistas de trpv1 e as respectivas utilizações
SG195136A1 (en) 2011-06-22 2013-12-30 Purdue Pharma Lp Trpv1 antagonists including dihydroxy substituent and uses thereof
CN102675217A (zh) * 2012-05-24 2012-09-19 盛世泰科生物医药技术(苏州)有限公司 一种5-溴-2-甲基-4(1h)-嘧啶酮的制备方法
CN110372602A (zh) * 2019-06-24 2019-10-25 南京普锐达医药科技有限公司 一种4-氯-2-甲基嘧啶的合成方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB959699A (en) * 1961-06-09 1964-06-03 May & Baker Ltd New pyrimidine derivatives
GB1143167A (en) * 1967-01-25 1969-02-19 Ucb Sa Derivatives of pyrimidine
US3859288A (en) * 1970-10-05 1975-01-07 Pfizer Arylpyrimidines - inhibitors of platelet aggregation and bronchodilators
US3707560A (en) * 1970-10-05 1972-12-26 Pfizer Certain 4-amino-6-aryl-pyrimidines
JPS5031157B1 (pt) * 1970-10-22 1975-10-07
NL7103449A (pt) * 1971-03-15 1972-09-19
DE2263052A1 (de) * 1972-12-22 1974-07-04 Wacker Chemie Gmbh Neue pyrimidine
CH595061A5 (pt) * 1974-05-10 1978-01-31 Ciba Geigy Ag
DE2433176C3 (de) * 1974-07-10 1979-06-07 Daiichi Seiyaku Co., Ltd., Tokio N-Cyano-cyano-acetimidate und Verfahren zur Herstellung von 2-Halopyrinüdinderivaten
US4191553A (en) 1978-03-02 1980-03-04 E. I. Du Pont De Nemours And Company Herbicidal sulfamates
CH643583A5 (de) * 1979-08-16 1984-06-15 Sandoz Ag Reaktivfarbstoffe sowie deren herstellung.
US4323681A (en) * 1980-09-29 1982-04-06 American Home Products Corporation 4-Amino-2-substituted-5-pyrimidinecarboxamidoximes and carbothioamides
LU86695A1 (fr) * 1986-12-01 1988-07-14 Oreal Nouveaux derives de piperazinyl-1 pyrimidine,leur preparation et leur application en therapeutique et cosmetique
US4900813A (en) * 1987-07-02 1990-02-13 Ciba-Geigy Corporation Fiber-reactive azo dyes having a 4,6-diaminopyridine coupling component
US4931455A (en) * 1988-01-07 1990-06-05 Ube Industries, Ltd. Alkylaminopyrimidine derivative and insecticide, acaricide and fungicide containing the same as active ingredient
EP0330263A1 (en) * 1988-02-25 1989-08-30 Merck & Co. Inc. Piperazinylalkylpyrimidines as hypoglycemic agents

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Ｊ．Ｃｈｅｍ．Ｓｏｃ．Ｐｅｒｋｉｎ ▲ＩＩ▼，１９７９（Ｎｏ．９）Ｐ１２４８−１２５２
Ｊｏｕｒｎａｌ ｏｆ Ｏｒｇａｎｉｃ Ｃｈｅｍｉｓｔｒｙ ｖｏｌ．５２（Ｎｏ．６）Ｐ１０１７−１０２１（１９８７）

Also Published As

Publication number Publication date
PT93224B (pt) 1996-09-30
DE3905364A1 (de) 1990-08-23
DK0384370T3 (da) 1994-03-07
FI900839A0 (fi) 1990-02-20
IE900627L (en) 1990-08-22
CA2010588A1 (en) 1990-08-22
NO178431B (no) 1995-12-18
AU634751B2 (en) 1993-03-04
JPH02255662A (ja) 1990-10-16
AU4997590A (en) 1990-08-30
FI95694C (fi) 1996-03-11
ATE96787T1 (de) 1993-11-15
EP0384370A1 (de) 1990-08-29
FI95694B (fi) 1995-11-30
IL93465A0 (en) 1990-11-29
CA2010588C (en) 2000-01-18
EP0384370B1 (de) 1993-11-03
NO900822D0 (no) 1990-02-21
PT93224A (pt) 1990-08-31
US5138058A (en) 1992-08-11
PH27222A (en) 1993-05-04
ZA901309B (en) 1990-10-31
KR900012916A (ko) 1990-09-03
NZ232601A (en) 1991-12-23
KR0142189B1 (ko) 1998-06-01
IE63570B1 (en) 1995-05-17
NO178431C (no) 1996-03-27
ES2060829T3 (es) 1994-12-01
IL93465A (en) 1995-03-30
DE59003274D1 (de) 1993-12-09
NO900822L (no) 1990-08-23

Similar Documents

Publication Publication Date Title
JP2955318B2 (ja) 置換ピリミジン誘導体
KR100443850B1 (ko) 헤테로시클릭 화합물의 도파민-ｄ３ 리간드로서의 용도
DE60203995T2 (de) Triazoloverbindungen als mmp-inhibitoren
US4209623A (en) Pyrimidine-5-N-(1H-tetrazol-5-yl)-carboxamides
SE437830B (sv) Analogiforfarande for framstellning av 3-(1h-tetrazol-5-yl)-4h-pyrido/1,2-a/pyrimidin-4-on-derivat
JPH0673024A (ja) キナゾリノン類及びピリドピリミジノン類
JP3094535B2 (ja) 置換ピリミジン誘導体
BE1005473A3 (fr) Derives heterocycliques.
US5340814A (en) 3-substituted methyl-2,3-dihydroimidazo[1,2-C] quinazoline derivatives, the preparation and use thereof
US4940712A (en) Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
EP0686631B1 (en) Pyrimidine derivatives and pharmaceutical compositions
DE69619868T2 (de) Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung
JP7362916B2 (ja) キサンチンオキシダーゼ阻害剤としてのチオフェン誘導体およびその使用
US4010159A (en) Pyrrolo[3,4-d]pyrimidines and methods for their preparation
JP3059572B2 (ja) ピロロ［３，２−ｅ］ピラゾロ［１，５−ａ］ピリミジン誘導体及びこれを有効成分とする高血圧治療剤
CA2359107A1 (en) New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
JPH0832705B2 (ja) 新規なメチル−２、３−ジヒドロイミダゾ〔１，２−ｃ〕キナゾリン誘導体、その製造法と用途
EP0153746B1 (en) 3-amino-2-hydroxypropyl derivatives of pyrimidin-4-one
JPH06271548A (ja) ４−ピリミジノン誘導体の塩、それらの製造および医療への応用
JPS62198684A (ja) ３−（１Ｈ−テトラゾ−ル−５−　イル）　チエノ〔２，３−ｄ〕　ピリミジン−４（３Ｈ）−オン類
JPH07118247A (ja) チアゾール酢酸誘導体
SI7812553A8 (sl) Postopek za pridobivanje novih hinazolinskih antihipertenzijskih sredstev
JPH0517480A (ja) 縮合イミダゾール誘導体

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20070716

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080716

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080716

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090716

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090716

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100716

Year of fee payment: 11

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100716

Year of fee payment: 11